Numinus to Participate in Upcoming Investor Conferences in April 2022
Numinus Wellness Inc. (TSX: NUMI, OTCQX: NUMIF) will participate in two virtual investor conferences in April 2022. Payton Nyquvest, Founder and CEO, is scheduled to present at the Sequire Cannabis & Psychedelic Conference on April 20 at 1:00 p.m. ET and at the KCSA Psychedelics Investor Conference on April 27 at 1:00 p.m. ET. Numinus focuses on mental health care, developing and delivering innovative therapies, including psychedelic-assisted treatments. For more details, visit www.numinus.com.
- None.
- None.
VANCOUVER, BC, April 7, 2022 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that Payton Nyquvest, Founder and CEO of Numinus, will participate in two upcoming investor conferences:
- Sequire Cannabis & Psychedelic Conference to be held virtually on Wednesday, April 20, 2022. Mr. Nyquvest will present at 1:00 p.m. ET. To attend, register here.
- KCSA Psychedelics Investor Conference to be held virtually on April 27-28, 2022. Mr. Nyquvest will present on Wednesday, April 27th at 1:00 p.m. ET. To attend, register here.
For more information about the conferences, or to schedule a one-on-one meeting with Numinus' management, please contact your appropriate representative directly, or send an email to KCSA Strategic Communications NuminusIR@kcsa.com.
Numinus Wellness helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model – including psychedelic production, research and clinic care – is at the forefront of a transformation aimed at healing rather than managing symptoms for depression, anxiety, trauma, pain and substance use. At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.
Learn more at www.numinus.com and follow us on LinkedIn, Facebook, Twitter, and Instagram.
Statements and other information contained in this press release about anticipated future events constitute forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as "seek", "anticipate", "believe", "plan", "estimate", "expect" and "intend" and statements that an event "may", "will", "should", "could" or "might" occur or other similar expressions. Forward-looking statements are subject to risks and uncertainties and other factors that could cause actual results to differ materially from those contained in the forward-looking statements. Forward-looking statements are based on estimates and opinions of management at the date the statements are made. The Company does not undertake any obligation to update forward-looking statements even if circumstances or management's estimates or opinions should change except as required by applicable laws. Investors should not place undue reliance on forward-looking statements.
View original content:https://www.prnewswire.com/news-releases/numinus-to-participate-in-upcoming-investor-conferences-in-april-2022-301519421.html
SOURCE Numinus Wellness Inc.
FAQ
When will Numinus participate in the Sequire Cannabis & Psychedelic Conference?
What is the date for the KCSA Psychedelics Investor Conference?
Who is presenting for Numinus at the investor conferences?
How can I register for the Numinus investor conference?
What is Numinus Wellness's focus in mental health care?
